article, page-396

THC Global Group Limited (ASX: THC)

The group operates under farm to pharma model and holds all three licenses to operate its domestic medical cannabis subsidiary. THC has significantly capacity of growing cannabis in its two sites along with industry-leading pharmaceuticals biomanufacturing facility, which makes the group in a prime position to capitalise on the growing domestic patient market and international export market.

In Australia, the group operates two world-class medicinal cannabis growing facilities with access to Australian cannabis strains as well as global imported strains. The Southport facility of the group is production ready for large scale pharmaceutical grade cannabis production for serving domestic as well as global markets.

THC last traded at AUD 0.460 on 17 June 2019, down by 3.158% from the prior close.